Atlantic Research Group
2421 Ivy Road
Tel: (434) 220-9380
About Atlantic Research Group
ARG is a rare disease, oncology and immunology-focused contract research organization that provides comprehensive clinical program development services ranging from pre-launch consulting to commercialization. Founded in 2004, ARG has experienced consistent growth across the globe, expanding our reach to include drug and device trial management in diverse and wide-ranging therapeutic areas. ARG has remained true to our original vision: every project is highly significant and visible, delivered through strategic collaboration with partners. ARG is rare for a reason: we successfully operationalize clinical development projects because we believe everyone deserves to be well.
6 articles with Atlantic Research Group
8/29/2019Companies from across the globe provide updates on their business and pipelines.
Atlantic Research Group (ARG), a full-service global contract research organization (CRO), has opened new European offices in Amsterdam and Warsaw. The corporate offices, combined with an existing London location, strengthen ARG’s global operations and set the stage for continued growth.
Inc. magazine collates an annual list of the fastest-growing private companies in America. This year, 15 of the top 5,000 were related to healthcare, medical devices and biopharma.
Atlantic Research Group Successfully Completes Work on Phase III Randomized, Multi-Center Clinical Trial Facilitating Lev Pharmaceuticals, Inc.'s BLA Submission